NICE recommends weekly insulin jab for type 2 diabetes patients

The National Institute for Health and Care Excellence ( NICE ) has recommended a new once-weekly basal insulin injection for adults with type 2 diabetes. The move could reduce the number of injections patients require each year by 85%. Under final draft guidance, insulin efsitora alfa (branded as Onswik and manufactured by Eli Lilly) is recommended as a treatment option for adults managing type 2…